- Home
- RNA vs STEP Comparison
RNA vs STEP Comparison
Compare RNA & STEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- STEP
- Stock Information
- Founded
- RNA 2012
- STEP 2007
- Country
- RNA United States
- STEP United States
- Employees
- RNA N/A
- STEP N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- STEP Finance/Investors Services
- Sector
- RNA Health Care
- STEP Finance
- Exchange
- RNA Nasdaq
- STEP Nasdaq
- Market Cap
- RNA 3.4B
- STEP 3.6B
- IPO Year
- RNA 2020
- STEP 2020
- Fundamental
- Price
- RNA $27.87
- STEP $54.78
- Analyst Decision
- RNA Strong Buy
- STEP Buy
- Analyst Count
- RNA 12
- STEP 7
- Target Price
- RNA $68.25
- STEP $64.21
- AVG Volume (30 Days)
- RNA 1.4M
- STEP 499.1K
- Earning Date
- RNA 05-08-2025
- STEP 05-22-2025
- Dividend Yield
- RNA N/A
- STEP 1.75%
- EPS Growth
- RNA N/A
- STEP N/A
- EPS
- RNA N/A
- STEP N/A
- Revenue
- RNA $8,927,000.00
- STEP $1,153,911,000.00
- Revenue This Year
- RNA N/A
- STEP $29.32
- Revenue Next Year
- RNA $135.33
- STEP $16.05
- P/E Ratio
- RNA N/A
- STEP N/A
- Revenue Growth
- RNA N/A
- STEP 118.88
- 52 Week Low
- RNA $21.51
- STEP $36.97
- 52 Week High
- RNA $56.00
- STEP $70.38
- Technical
- Relative Strength Index (RSI)
- RNA 45.31
- STEP 59.66
- Support Level
- RNA $25.58
- STEP $52.62
- Resistance Level
- RNA $33.62
- STEP $55.99
- Average True Range (ATR)
- RNA 2.09
- STEP 1.83
- MACD
- RNA -0.29
- STEP 0.87
- Stochastic Oscillator
- RNA 28.53
- STEP 88.04
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.